本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Adverum Biotechnologies, Inc.

3.52
+0.350011.04%
盘后3.590.0700+1.99%19:34 EDT
成交量:17.26万
成交额:59.17万
市值:7,386.42万
市盈率:-0.43
高:3.57
开:3.22
低:3.18
收:3.17
52周最高:8.56
52周最低:1.78
股本:2,098.42万
流通股本:1,136.27万
量比:3.58
换手率:1.52%
股息:- -
股息率:- -
每股收益(TTM):-8.1048
每股收益(LYR):-6.6185
净资产收益率:-229.34%
总资产收益率:-62.55%
市净率:-3.65
市盈率(LYR):-0.53

数据加载中...

2023/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/11

重要事件披露

8-K - Current report
2023/04/28

SEC问询函

Form CORRESP - Correspondence
2023/04/20

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/30

重要事件披露

8-K - Current report
2023/03/30

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/30

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/30

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/13

重要事件披露

8-K - Current report
2022/11/25

重要事件披露

8-K - Current report
2022/11/10

重要事件披露

8-K - Current report
2022/11/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/09/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/08/11

重要事件披露

8-K - Current report
2022/08/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]